CFS Netralaya Private Limited

CFS Netralaya Private Limited - healthcare in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U52100MH2011PTC338351 Incorporated 14 February 2011 ROC Mumbai HQ Mumbai, Maharashtra, India
Merged Private Limited Company healthcare
Data last updated
Revenue · FY 2023
₹1 Cr
▼ 6% YoY
Net loss · FY 2023
₹41.35 Lakh
Net margin -41.2%
EBITDA · FY 2023
-₹78.56 Lakh
EBITDA margin -78.2%
Authorised capital
₹2.6 Cr
Registered with MCA
Paid-up capital
₹1.92 Cr
Issued & subscribed
Company age
15 yrs
Est. 2011
Employees · EPFO
44
Provident fund records
Directors on board
3
As per MCA filings

About CFS Netralaya Private Limited

Data last updated:

CFS Netralaya Private Limited was a private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of New Delhi Centre For Sight Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the eye care and ophthalmology clinics segment of the healthcare sector. It was incorporated on 14 February 2011.

The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U52100MH2011PTC338351. The company has 2 GST registrations on record, none of which is active.

The company had an authorised share capital of ₹2.6 Cr and a paid-up capital of ₹1.92 Cr. It was led by directors including Mahipal Singh Sachdev and Alka Sachdev.

Its last annual general meeting (AGM) was held on 27 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Mumbai, Maharashtra.

As per the financials filed for FY 2023, the company reported a revenue of ₹1 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net loss of ₹41.35 Lakh (net margin -41.2%) and EBITDA of -₹78.56 Lakh (EBITDA margin -78.2%). Revenue has declined at a compounded annual rate (CAGR) of 57% over three years and 40% over five years.

The company had about 44 employees on its provident fund (EPFO) records before it was dissolved.

Court records list 4 cases involving the company, including 4 filed by the company.

The last known website on record is centreforsight.net.

Company details

CIN U52100MH2011PTC338351
Registration Number 338351
Incorporation Date 14 February 2011
ROC Mumbai
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 27 September 2023
Date of Balance Sheet 31 March 2023
Parent Company New Delhi Centre For Sight Limited
Compliance Status Active Compliant

CIN history

CFS Netralaya has one previous CIN (Corporate Identification Number): U52100DL2011PTC214013. The current CIN is U52100MH2011PTC338351, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U52100MH2011PTC338351Current
U52100DL2011PTC214013Previous

Contact details

CFS Netralaya Private Limited's registered office is in Mumbai, Maharashtra. Its website is centreforsight.net. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    First Floor Flat No. 101 B Wing Dhruv Chsl Gulmohar Main Road Juhu Ville Par, Le, Mumbai, Maharashtra, India – 400049
  • Industry
    Healthcare, Eye Care & Ophthalmology Clinics

To see the full contact details of CFS Netralaya Private Limited, buy the company report.

Comprehensive company report
CFS Netralaya Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of CFS Netralaya Private Limited

FY 2023 filings available

CFS Netralaya Private Limited reported revenue of ₹1 Cr (down 6% YoY) for FY 2023.

Revenue · FY 2023
₹1 Cr ▼ 6%
Net loss · FY 2023
₹41.35 Lakh margin -41.2%
EBITDA · FY 2023
-₹78.56 Lakh margin -78.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▼ 57%
5 years · compounded
▼ 40%

Revenue has declined at a compounded annual rate (CAGR) of 40% over five years, including a 6% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹1 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹78.56 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹41.35 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin-78.2%
Net Profit Margin-41.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of CFS Netralaya Private Limited, buy the company report.

Board of directors of CFS Netralaya Private Limited

CFS Netralaya has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Mahipal Singh SachdevDirector14 Feb 201115 Years 8 MonthsAs last reported
Alka SachdevDirector30 Mar 201115 Years 6 MonthsAs last reported
Ritika Sachdev GuptaDirector01 Sep 201214 Years 1 MonthsAs last reported

Auditor

CFS Netralaya Private Limited is audited by Rajan Malik & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Rajan Malik & Co.FY 2023019859N

Shareholding

The shareholding of CFS Netralaya Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of CFS Netralaya Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for CFS Netralaya Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

CFS Netralaya Private Limited has a workforce of 44 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.

Employee count
44
Active EPFO establishments
1
Employee growth
-2.22%

GST

CFS Netralaya has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.

Total GSTINs
2
Cancelled / inactive
2

To see the full GST registrations and return filing status of CFS Netralaya Private Limited, buy the company report.

Recent activity

CFS Netralaya Private Limited has 9 board changes on record since 2011: 3 appointments and 6 cessations. The latest: Roop ceased to be Director on 24 Mar 2023.

AGM
Cfs Netralaya Private Limited last Annual general meeting of members was held on 27 Sep 2023 as per latest MCA records.
Filing
Cfs Netralaya Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Ceased
Roop ceased to be Director.
Ceased
Shimant Bhushan Chadha ceased to be Director.
Ceased
Umang Varma ceased to be Director.
Ceased
Ritika Sachdev Gupta ceased to be Additional Director.
Appointed
Ritika Sachdev Gupta was appointed as Director.
Ceased
Alka Sachdev ceased to be Additional Director.
Ceased
Sangeeta ceased to be Additional Director.
Appointed
Alka Sachdev was appointed as Director.
Appointed
Mahipal Singh Sachdev was appointed as Director.
Incorporation
14 Feb 2011
Cfs Netralaya Private Limited was registered on 14 Feb 2011 with Roc Mumbai & aged 15 years 8 months as per MCA records.

Frequently asked questions

CFS Netralaya has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

CFS Netralaya was a private limited company based in Mumbai, Maharashtra, India. The company worked in eye care and ophthalmology clinics, within the healthcare industry. It was incorporated on 14 February 2011 and is registered under CIN U52100MH2011PTC338351. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.

CFS Netralaya was incorporated on 14 February 2011. It is registered with the Registrar of Companies, Mumbai.

CFS Netralaya had 3 directors:

The CIN (Corporate Identification Number) of CFS Netralaya is U52100MH2011PTC338351. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of CFS Netralaya is at First Floor Flat No. 101 B Wing Dhruv Chsl Gulmohar Main Road Juhu Ville Par, Le, Mumbai, Maharashtra, India – 400049.

CFS Netralaya can be reached through the website centreforsight.net. Its registered office is in Mumbai, Maharashtra, India.

The latest financial statements of CFS Netralaya on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 27 September 2023. Year-wise statements from 2015 are in the company report.

No. CFS Netralaya has 2 GST registrations on record and all of them are cancelled or inactive.

CFS Netralaya operated in the healthcare industry, in the eye care and ophthalmology clinics segment.